Literature DB >> 3792465

Major intrinsic polypeptide (MIP26K) from human lens membrane: characterization of low-molecular-weight forms in the aging human lens.

L Takemoto, M Takehana.   

Abstract

Antisera made against a C-terminal octapeptide of bovine MIP26K and against an N-terminal nonapeptide from the same protein have been used to determine the location of age-dependent cleavage sites of MIP26K in the human lens. Neither the C-terminal antiserum (anti-MIP26K256-263) nor the N-terminal antiserum (anti-MIP26K1-9) binds to the 22,000 MW form of MIP26K, suggesting cleavage from both the N- and C-terminus during lens aging. Anti-MIP26K256-263, but not anti-MIP26K1-9, binds to 20,000 and 15,000 MW forms of MIP26K, demonstrating that age-dependent production of these forms occurs by cleavage from the N-terminal side of the molecule. Together, these results show that age-dependent processing of MIP26K in the human lens occurs from both ends of the molecule, with cleavage from the N-terminal end being mainly responsible for production of the lower-molecular-weight 20,000 and 15,000 MW components.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792465     DOI: 10.1016/s0014-4835(86)80032-x

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  3 in total

1.  Spatial analysis of human lens aquaporin-0 post-translational modifications by MALDI mass spectrometry tissue profiling.

Authors:  Danielle B Gutierrez; Donita Garland; Kevin L Schey
Journal:  Exp Eye Res       Date:  2011-10-25       Impact factor: 3.467

2.  MALDI imaging mass spectrometry of integral membrane proteins from ocular lens and retinal tissue.

Authors:  Angus C Grey; Pierre Chaurand; Richard M Caprioli; Kevin L Schey
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

Review 3.  Lens Aquaporins in Health and Disease: Location is Everything!

Authors:  Kevin L Schey; Romell B Gletten; Carla V T O'Neale; Zhen Wang; Rosica S Petrova; Paul J Donaldson
Journal:  Front Physiol       Date:  2022-04-19       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.